Alcon AG | ALC - Себестоимость





Себестоимость Изменить Дата
AstraZeneca USD 2.78B 260M 2026-09
Bayer EUR 4.6B 61M 2026-09
Essilor EUR 5.55B 505M 2026-06
Fresenius EUR 4.35B 44M 2026-09
Fresenius Medical Care EUR 3.66B 110.42M 2026-09
GlaxoSmithKline GBP 2.23B 163M 2026-09
GRIFOLS EUR 1.23B 63M 2026-09
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.25B 20M 2026-09
Novartis USD 3.57B 137M 2026-09
Philips EUR 2.35B 143M 2026-09
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 4.19B 1.17B 2026-09
Smith & Nephew USD 901M 31M 2026-06
Sonova Holding CHF 539.4M 11.5M 2025-12
UCB EUR 1.07B 146M 2025-12